Bollore Logistics gets IATA CEIV Pharma at Japan’s Kansai Airport

April 3, 2019: Last week Bollore Logistics Japan was awarded the International Air Transport Association (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification for its platform located in the Kansai International Airport (KIX), in Osaka. The certification is a globally recognised and standardised certification for healthcare airfreight shipments. Bollore Logistics […]

Bollore Logistics gets IATA CEIV Pharma at Japan’s Kansai Airport
X

April 3, 2019: Last week Bollore Logistics Japan was awarded the International Air Transport Association (IATA) Center of Excellence for Independent Validators in Pharmaceutical Logistics (CEIV Pharma) certification for its platform located in the Kansai International Airport (KIX), in Osaka.

The certification is a globally recognised and standardised certification for healthcare airfreight shipments.

Bollore Logistics Japan began the certification process according to the IATA CEIV Pharma standards in the second quarter of 2017.

"Earning the CEIV Pharma certification demonstrates our ability to successfully build and deploy a team of experts who are fully capable to offer end-to-end logistics solution for the pharmaceutical related temperature sensitive products through the Kansai International Airport (KIX). In the near future, we are also keen to acquire the same certification in Haneda Airport (Tokyo) in order for us to expand the expertise nationwide," said Goro UMEZAWA, Sales Manager at Bollor Logistics Japan.

The company has already received certifications on its sites in Australia, Singapore, South Korea, China and now Japan.

This is in addition to on-going certifications on other sites in the Asia-Pacific region such as China Hong Kong.

In Europe, Bollore Logistics has already received the IATA CEIV Pharma certification for its Paris Roissy CDG platform (France) as well as its sites in Brussels (Belgium), Frankfurt (Germany) and Lisbon (Portugal).

Read Full Article
Next Story
Share it